Biomaterial Database

Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Lebanon. 1996

M Uwaydah, and M Jradeh, and Z Shihab

Department of Medicine, American University of Beirut Medical Center, Lebanon.

A total of 61 clinical isolates of Streptococcus pneumoniae from Lebanon were tested for their susceptibility to penicillin G and seven other antibiotics by the agar dilution technique. All penicillin-susceptible isolates were also susceptible to chloramphenicol, ceftriaxone and erythromycin. Penicillin-resistant isolates were consistently susceptible only to erythromycin.

UI	MeSH Term	Description	Entries
D007861	Lebanon	A country located in the Middle East, bordering the Mediterranean Sea, between Israel and Syria. The capital is Beirut.	Lebanese Republic
D010400	Penicillin G	A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.	Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin Grünenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D002433	Cefaclor	Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.	5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002443	Ceftriaxone	A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.	Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D002701	Chloramphenicol	An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)	Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D002969	Clavulanic Acids	Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.	Acids, Clavulanic
D004352	Drug Resistance, Microbial	The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).	Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004359	Drug Therapy, Combination	Therapy with two or more separate preparations given for a combined effect.	Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004917	Erythromycin	A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.	Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Uwaydah, and M Jradeh, and Z Shihab

Increasing antimicrobial resistance in clinical isolates of Streptococcus pneumoniae.

September 1997, Annals of the Academy of Medicine, Singapore,

M Uwaydah, and M Jradeh, and Z Shihab

Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Istanbul.

September 2000, International journal of antimicrobial agents,

M Uwaydah, and M Jradeh, and Z Shihab

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America.

July 1999, The American journal of medicine,

M Uwaydah, and M Jradeh, and Z Shihab

Antimicrobial resistance of Streptococcus pneumoniae isolates in Athens, Greece.

October 2005, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

M Uwaydah, and M Jradeh, and Z Shihab

National antimicrobial resistance surveillance among clinical isolates of Streptococcus pneumoniae in Thailand.

August 2009, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,

M Uwaydah, and M Jradeh, and Z Shihab

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.

May 2002, Antimicrobial agents and chemotherapy,

M Uwaydah, and M Jradeh, and Z Shihab

[Antibiotic resistance of clinical isolates Streptococcus pneumoniae].

May 1996, Rinsho byori. The Japanese journal of clinical pathology,

M Uwaydah, and M Jradeh, and Z Shihab

[Prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in a children's hospital].

May 1997, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,